Tumor immune response enhancing complex

Abstract

The invention discloses a tumor immune response enhancing complex. The tumor immune response enhancing complex is formed through in vitro binding of tumor cell peptides, salmon ovarian peptides and heat shock protein 70, wherein the tumor cell peptides are peptides obtained from tumor cells and contain tumor specific antigen peptides. The tumor immune response enhancing complex can inhibit growth of tumor cells and meanwhile eliminate tumor necrosis factors, thereby greatly enhancing the function of inhibiting tumor growth.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a compound for enhancing anti-tumor immune response. Background technique [0002] Most of the existing complexes that enhance anti-tumor immune response are obtained by combining heat shock protein 70 or heat shock protein 90 with tumor cell mixed peptides. Although they can inhibit the growth of tumor cells to a certain extent, they cannot remove necrosis factors . Contents of the invention [0003] In order to solve the above problems, the present invention provides a complex for enhancing anti-tumor immune response, which can remove necrosis factors while inhibiting tumor cell growth, thereby greatly improving the inhibitory function on tumor growth. [0004] In order to achieve the above object, the technical scheme that the present invention takes is: [0005] A complex for enhancing anti-tumor immune response, which is obtained by combining tumor cell mixed peptide, salmon o...

AI Technical Summary

Problems solved by technology

[0002] Most of the existing complexes that enhance anti-tumor immune response are obtained by combining heat shock protein 70 or heat shock protein 90 with tumor cell mixed peptides. Although they can inhibit the growth of tumor cells to a certain extent, they cannot remove necrosis factors